| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DC.21191 |
| P698 | PubMed publication ID | 19856423 |
| P2093 | author name string | Lydia Pleotis Howell | |
| Alaa Afify | |||
| John Bishop | |||
| Maaya Wilton | |||
| P2860 | cites work | Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study | Q30307042 |
| Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls | Q30844044 | ||
| HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial | Q31044179 | ||
| Do qualifiers of ASCUS distinguish between low- and high-risk patients? | Q33647459 | ||
| Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. | Q33923869 | ||
| The 2001 Bethesda System: terminology for reporting results of cervical cytology | Q34124761 | ||
| 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities | Q34124766 | ||
| Human papillomavirus and Papanicolaou tests to screen for cervical cancer | Q34702284 | ||
| The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion | Q35568192 | ||
| Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses | Q36584432 | ||
| Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting | Q36615447 | ||
| Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored | Q36684175 | ||
| 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests | Q36955449 | ||
| ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants | Q39548781 | ||
| Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors | Q40615316 | ||
| Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial | Q40868813 | ||
| Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). | Q41032738 | ||
| Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance | Q41133564 | ||
| "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence | Q43424946 | ||
| Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods | Q43587924 | ||
| Impact of ASC-H terminology on the detection of HSILs in medically underserved California women | Q43589611 | ||
| Outcome of "Atypical squamous cells" in a cervical cytology screening program: implications for follow up in resource limited settings | Q44294578 | ||
| Role of Pap Test terminology and age in the detection of carcinoma invasive and carcinoma in situ in medically underserved California women. | Q46013237 | ||
| Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? | Q48722666 | ||
| The "ASCUS" swamp. | Q52880964 | ||
| Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. | Q52882445 | ||
| Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 | ||
| Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management. | Q53597728 | ||
| Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. | Q53631920 | ||
| Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. | Q55066000 | ||
| Overview of the European and North American studies on HPV testing in primary cervical cancer screening | Q57414808 | ||
| Apparent Transmission of Hodgkin's Disease | Q66961079 | ||
| Current use of the Papanicolaou class system in gynecologic cytology | Q69060860 | ||
| Atypical or suspicious cervical smears. An aggressive diagnostic approach | Q69460574 | ||
| Reactive change and atypical squamous cells of undetermined significance in Papanicolaou smears: a cytohistologic correlation | Q72658599 | ||
| Atypical squamous cells of undetermined significance--rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates | Q73439874 | ||
| Smears diagnosed as ASCUS: interobserver variation and follow-up | Q74287961 | ||
| Natural history of dysplasia of the uterine cervix | Q74484240 | ||
| A follow-up study of atypical squamous cells in gynecologic cytology using conventional papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001 | Q79973847 | ||
| Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant? | Q80113050 | ||
| The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests | Q80177805 | ||
| Applicability of the Bethesda System 2001 to a public health setting | Q80202020 | ||
| Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results | Q81149864 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" : an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia | Q81433375 | ||
| Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category | Q81491774 | ||
| Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H) | Q81628534 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 221-232 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Diagnostic Cytopathology | Q15750060 |
| P1476 | title | Living with uncertainty: equivocal Pap test results and the evolution of ASC terminology | |
| P478 | volume | 38 |
Search more.